For instance, miR-214 was notably deregulated in human ovarian cancer and significantly induced cisplatin resistance by targeting PTEN, whereas upregulated miR-214 promoted sensitivity to cisplatin in cervical cancer cells [34, 35]. This evidence concerns the gene PTEN and cervical carcinoma.